SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001274644-16-000150
Filing Date
2016-11-02
Accepted
2016-11-02 16:51:39
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q- SEPTEMBER 2016 ocera3q-201610q.htm 10-Q 678517
2 EXHIBIT 31.1 CEO CERTIFICATION ocrxexhibit3113q2016.htm EX-31.1 16637
3 EXHIBIT 31.2 CFO CERTIFICATION ocrxexhibit3123q2016.htm EX-31.2 16726
4 EXHIBIT 32.1 SEC.906 CEO CERTIFICATION ocrxexhibit3213q2016.htm EX-32.1 7407
5 EXHIBIT 32.2 SEC. 906 CFO CERTIFICATION ocrxexhibit3223q2016.htm EX-32.2 7014
12 newoceralogoa06.jpg GRAPHIC 11170
  Complete submission text file 0001274644-16-000150.txt   3981609

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ocrx-20160930.xml EX-101.INS 806526
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocrx-20160930.xsd EX-101.SCH 27012
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocrx-20160930_cal.xml EX-101.CAL 58299
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocrx-20160930_def.xml EX-101.DEF 135802
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocrx-20160930_lab.xml EX-101.LAB 446742
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocrx-20160930_pre.xml EX-101.PRE 254645
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 161968695
SIC: 2834 Pharmaceutical Preparations